Subject and method: Studied on 44 fT2DM, who were selected for monotherapy treatment with sitagliptin (100mg / day) for 12 - 14 weeks, 48 patients with T2DM who are being treated over one year (T2DM group) and 52 healthy people in National Endocrinology Hospital.